The global cancer cachexia therapeutics market demonstrates significant growth, driven by the rising prevalence of cancer worldwide and a flourishing demand for effective treatment options. Cachexia, a debilitating syndrome characterized by marked weight loss and muscle wasting, affects a substantial proportion of cancer patients, considerably impa